2nd RNA-Based Therapeutics and Vaccines South Korea
17 17 people viewed this event.
South Korea’s mRNA ecosystem is rapidly advancing, fueled by progress from companies like GC Biopharma and EyeGene in clinical-stage vaccines. Also, with the growing momentum of ARPA-H initiatives focused on personalized mRNA cancer therapies and strong government backing continues to drive the development of safer, more effective RNA-based medicines.
Date and Time: Tuesday, 10 November 2026 at 08:30 – Thursday, 12 November 2026 at 15:15
Venue details: Grand Hyatt Incheon, 208 Yeongjonghaeannam-ro 321beon-gil, Jung-gu, Incheon, 22382, Korea (South)
Prices:
USD 1599.00 – USD 5149.00
Event Organizer - Hanson Wade
Full Name - Jessica Durston
Email - info@hansonwade.com